Vanderbilt University Medical Center
Dr. Katy Beckermann is an assistant professor and Vanderbilt University Medical Center. She specializes in genitourinary medical oncology treating patients with kidney, prostate, bladder, and testicular caner. Her research passion involves biomarker and drug development in kidney cancer where she is participates in both clinical trials and translational research.
Aravive (Individual(s) Involved: Self; Clinical Condition: oncology): Advisory Board; Astellas Pharma, Inc. (Individual(s) Involved: Self): Advisory Board; Aveo (Individual(s) Involved: Self; Clinical Condition: oncology): Advisory Board; Bristol-Meyers-Squibb (Individual(s) Involved: Self): Advisory Board; Cook, Eisai, BSci, Exelixis (Individual(s) Involved: Self): Advisory Board; rbi (Individual(s) Involved: Self): Grant/Research Support; Sanofi/Genzyme (Individual(s) Involved: Self): Advisory Board; Seagen, Inc. (Individual(s) Involved: Self): Advisory Board
Thursday, September 29, 2022
9:40 AM – 11:50 AM
Thursday, September 29, 2022
11:05 AM – 11:25 AM
Thursday, September 29, 2022
11:25 AM – 11:50 AM